The Cost-Effectiveness of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer in Norway

Background. Expansion of routine genetic testing for hereditary breast and ovarian cancer from conventional BRCA testing to a multigene test could improve diagnostic yield and increase the opportunity for cancer prevention in both identified carriers and their relatives. We use an economic decision...

Descripción completa

Detalles Bibliográficos
Autores principales: Asphaug, Lars, Melberg, Hans Olav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360477/
https://www.ncbi.nlm.nih.gov/pubmed/30746499
http://dx.doi.org/10.1177/2381468318821103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360477/
https://www.ncbi.nlm.nih.gov/pubmed/30746499
http://dx.doi.org/10.1177/2381468318821103

Ejemplares similares